1 | individual | 19,714 |
2 | individual-level | 250 |
3 | all-day | 18 |
4 | stone-forming | 17 |
5 | archaic | 13 |
6 | misconceived | 12 |
7 | asthma/copd | 9 |
8 | ethnicity-specific | 7 |
9 | information-rich | 7 |
10 | hookah-related | 6 |
11 | provider-specific | 6 |
12 | 2517 | 5 |
13 | aids-specific | 5 |
14 | end-digit | 5 |
15 | at-scene | 4 |
16 | foot-specific | 4 |
17 | juror | 4 |
18 | non-adc | 4 |
19 | pain-sensitive | 4 |
20 | pre-to-postsleep | 4 |
21 | ac-rct | 3 |
22 | cisapride-treated | 3 |
23 | dance-specific | 3 |
24 | hla-typed | 3 |
25 | igniting | 3 |
26 | iocv2 | 3 |
27 | kamlet-taft | 3 |
28 | sulfur-free | 3 |
29 | tenecteplase-treated | 3 |
30 | 'empowered | 2 |
31 | 11-question | 2 |
32 | 13,296 | 2 |
33 | 258,544 | 2 |
34 | 3,271 | 2 |
35 | 303000 | 2 |
36 | 5,896 | 2 |
37 | 5396 | 2 |
38 | 6,602 | 2 |
39 | 67,774 | 2 |
40 | 8-ounce | 2 |
41 | 80-kg | 2 |
42 | amb-treated | 2 |
43 | cefmenoxime-treated | 2 |
44 | cme/ce | 2 |
45 | community-initiated | 2 |
46 | dentulous | 2 |
47 | dex-sedated | 2 |
48 | difficult-to-cure | 2 |
49 | disease.the | 2 |
50 | genderspecific | 2 |
51 | hifu-treated | 2 |
52 | home-sent | 2 |
53 | icf-based | 2 |
54 | inter-shift | 2 |
55 | jth | 2 |
56 | line-item | 2 |
57 | lpl-deficient | 2 |
58 | molecular/genetic | 2 |
59 | moroccan-dutch | 2 |
60 | nine-question | 2 |
61 | non-penicillin-allergic | 2 |
62 | nonprivileged | 2 |
63 | normal-energy | 2 |
64 | 1.59/1,000 | 1 |
65 | 1178400 | 1 |
66 | 118/1000 | 1 |
67 | 126,220 | 1 |
68 | 13,361 | 1 |
69 | 16,504 | 1 |
70 | 16.3/1000 | 1 |
71 | 17.3/1,000 | 1 |
72 | 172nd | 1 |
73 | 21,002 | 1 |
74 | 25.0/1,000 | 1 |
75 | 269,956 | 1 |
76 | 28,780 | 1 |
77 | 3,663 | 1 |
78 | 33,574 | 1 |
79 | 33,795 | 1 |
80 | 4,873 | 1 |
81 | 4.0/10000 | 1 |
82 | 45,483 | 1 |
83 | 485,166 | 1 |
84 | 5.25/1,000 | 1 |
85 | 7,406 | 1 |
86 | 73,454 | 1 |
87 | 73,651 | 1 |
88 | 8,850 | 1 |
89 | 8496 | 1 |
90 | 93-kg | 1 |
91 | addiction-focused | 1 |
92 | appropriategenetic | 1 |
93 | ascites-positive | 1 |
94 | asplenic | 1 |
95 | average-reported | 1 |
96 | beck-positive | 1 |
97 | caregiver-dementia | 1 |
98 | child/your | 1 |
99 | clopidogrel/aspirin-treated | 1 |
100 | comparison.ten | 1 |
101 | d'un | 1 |
102 | da-supported | 1 |
103 | destigmatized | 1 |
104 | difficult-to-ventilate | 1 |
105 | disability-avoided | 1 |
106 | egfr-unselected | 1 |
107 | exiguous | 1 |
108 | frst | 1 |
109 | ganrantee | 1 |
110 | guideline-related | 1 |
111 | heparin-exposed | 1 |
112 | high-cancer-risk | 1 |
113 | hygiene/burroughs | 1 |
114 | hypophosphataemia/1000 | 1 |
115 | immunossupressed | 1 |
116 | investigació | 1 |
117 | lamonica-oberst | 1 |
118 | mh-treated | 1 |
119 | multi-structural | 1 |
120 | nine-symptom | 1 |
121 | no-pcr | 1 |
122 | non-anaesthetised | 1 |
123 | non-npc | 1 |
124 | non-sep | 1 |
125 | pertuzumab-treated | 1 |
126 | post-alcohol-withdrawal | 1 |
127 | poverty-level | 1 |
128 | pre-ecmo | 1 |
129 | progesterone-deficient | 1 |
130 | purpose-made | 1 |
131 | reverifying | 1 |
132 | rhd-alloimmunized | 1 |
133 | sponge-using | 1 |
134 | sulfasalazine-sensitive | 1 |
135 | uncomplaining | 1 |
136 | unconsentable | 1 |
137 | unfollowed | 1 |
138 | worse-off | 1 |
139 | worst-off | 1 |
1 | 'empowered | 2 |
2 | 1.59/1,000 | 1 |
3 | 11-question | 2 |
4 | 1178400 | 1 |
5 | 118/1000 | 1 |
6 | 126,220 | 1 |
7 | 13,296 | 2 |
8 | 13,361 | 1 |
9 | 16,504 | 1 |
10 | 16.3/1000 | 1 |
11 | 17.3/1,000 | 1 |
12 | 172nd | 1 |
13 | 21,002 | 1 |
14 | 25.0/1,000 | 1 |
15 | 2517 | 5 |
16 | 258,544 | 2 |
17 | 269,956 | 1 |
18 | 28,780 | 1 |
19 | 3,271 | 2 |
20 | 3,663 | 1 |
21 | 303000 | 2 |
22 | 33,574 | 1 |
23 | 33,795 | 1 |
24 | 4,873 | 1 |
25 | 4.0/10000 | 1 |
26 | 45,483 | 1 |
27 | 485,166 | 1 |
28 | 5,896 | 2 |
29 | 5.25/1,000 | 1 |
30 | 5396 | 2 |
31 | 6,602 | 2 |
32 | 67,774 | 2 |
33 | 7,406 | 1 |
34 | 73,454 | 1 |
35 | 73,651 | 1 |
36 | 8,850 | 1 |
37 | 8-ounce | 2 |
38 | 80-kg | 2 |
39 | 8496 | 1 |
40 | 93-kg | 1 |
41 | ac-rct | 3 |
42 | addiction-focused | 1 |
43 | aids-specific | 5 |
44 | all-day | 18 |
45 | amb-treated | 2 |
46 | appropriategenetic | 1 |
47 | archaic | 13 |
48 | ascites-positive | 1 |
49 | asplenic | 1 |
50 | asthma/copd | 9 |
51 | at-scene | 4 |
52 | average-reported | 1 |
53 | beck-positive | 1 |
54 | caregiver-dementia | 1 |
55 | cefmenoxime-treated | 2 |
56 | child/your | 1 |
57 | cisapride-treated | 3 |
58 | clopidogrel/aspirin-treated | 1 |
59 | cme/ce | 2 |
60 | community-initiated | 2 |
61 | comparison.ten | 1 |
62 | d'un | 1 |
63 | da-supported | 1 |
64 | dance-specific | 3 |
65 | dentulous | 2 |
66 | destigmatized | 1 |
67 | dex-sedated | 2 |
68 | difficult-to-cure | 2 |
69 | difficult-to-ventilate | 1 |
70 | disability-avoided | 1 |
71 | disease.the | 2 |
72 | egfr-unselected | 1 |
73 | end-digit | 5 |
74 | ethnicity-specific | 7 |
75 | exiguous | 1 |
76 | foot-specific | 4 |
77 | frst | 1 |
78 | ganrantee | 1 |
79 | genderspecific | 2 |
80 | guideline-related | 1 |
81 | heparin-exposed | 1 |
82 | hifu-treated | 2 |
83 | high-cancer-risk | 1 |
84 | hla-typed | 3 |
85 | home-sent | 2 |
86 | hookah-related | 6 |
87 | hygiene/burroughs | 1 |
88 | hypophosphataemia/1000 | 1 |
89 | icf-based | 2 |
90 | igniting | 3 |
91 | immunossupressed | 1 |
92 | individual | 19,714 |
93 | individual-level | 250 |
94 | information-rich | 7 |
95 | inter-shift | 2 |
96 | investigació | 1 |
97 | iocv2 | 3 |
98 | jth | 2 |
99 | juror | 4 |
100 | kamlet-taft | 3 |
101 | lamonica-oberst | 1 |
102 | line-item | 2 |
103 | lpl-deficient | 2 |
104 | mh-treated | 1 |
105 | misconceived | 12 |
106 | molecular/genetic | 2 |
107 | moroccan-dutch | 2 |
108 | multi-structural | 1 |
109 | nine-question | 2 |
110 | nine-symptom | 1 |
111 | no-pcr | 1 |
112 | non-adc | 4 |
113 | non-anaesthetised | 1 |
114 | non-npc | 1 |
115 | non-penicillin-allergic | 2 |
116 | non-sep | 1 |
117 | nonprivileged | 2 |
118 | normal-energy | 2 |
119 | pain-sensitive | 4 |
120 | pertuzumab-treated | 1 |
121 | post-alcohol-withdrawal | 1 |
122 | poverty-level | 1 |
123 | pre-ecmo | 1 |
124 | pre-to-postsleep | 4 |
125 | progesterone-deficient | 1 |
126 | provider-specific | 6 |
127 | purpose-made | 1 |
128 | reverifying | 1 |
129 | rhd-alloimmunized | 1 |
130 | sponge-using | 1 |
131 | stone-forming | 17 |
132 | sulfasalazine-sensitive | 1 |
133 | sulfur-free | 3 |
134 | tenecteplase-treated | 3 |
135 | uncomplaining | 1 |
136 | unconsentable | 1 |
137 | unfollowed | 1 |
138 | worse-off | 1 |
139 | worst-off | 1 |
1 | 25.0/1,000 | 1 |
2 | 17.3/1,000 | 1 |
3 | 5.25/1,000 | 1 |
4 | 1.59/1,000 | 1 |
5 | 4.0/10000 | 1 |
6 | 16.3/1000 | 1 |
7 | 118/1000 | 1 |
8 | hypophosphataemia/1000 | 1 |
9 | 303000 | 2 |
10 | 1178400 | 1 |
11 | 126,220 | 1 |
12 | 8,850 | 1 |
13 | 28,780 | 1 |
14 | 73,651 | 1 |
15 | 13,361 | 1 |
16 | 3,271 | 2 |
17 | 21,002 | 1 |
18 | 6,602 | 2 |
19 | iocv2 | 3 |
20 | 3,663 | 1 |
21 | 4,873 | 1 |
22 | 45,483 | 1 |
23 | 16,504 | 1 |
24 | 258,544 | 2 |
25 | 73,454 | 1 |
26 | 33,574 | 1 |
27 | 67,774 | 2 |
28 | 33,795 | 1 |
29 | 7,406 | 1 |
30 | 269,956 | 1 |
31 | 485,166 | 1 |
32 | 13,296 | 2 |
33 | 5396 | 2 |
34 | 8496 | 1 |
35 | 5,896 | 2 |
36 | 2517 | 5 |
37 | caregiver-dementia | 1 |
38 | non-adc | 4 |
39 | archaic | 13 |
40 | dance-specific | 3 |
41 | provider-specific | 6 |
42 | aids-specific | 5 |
43 | foot-specific | 4 |
44 | ethnicity-specific | 7 |
45 | genderspecific | 2 |
46 | non-penicillin-allergic | 2 |
47 | asplenic | 1 |
48 | molecular/genetic | 2 |
49 | appropriategenetic | 1 |
50 | non-npc | 1 |
51 | disability-avoided | 1 |
52 | nonprivileged | 2 |
53 | hla-typed | 3 |
54 | 'empowered | 2 |
55 | icf-based | 2 |
56 | non-anaesthetised | 1 |
57 | heparin-exposed | 1 |
58 | immunossupressed | 1 |
59 | addiction-focused | 1 |
60 | dex-sedated | 2 |
61 | pertuzumab-treated | 1 |
62 | amb-treated | 2 |
63 | cisapride-treated | 3 |
64 | cefmenoxime-treated | 2 |
65 | tenecteplase-treated | 3 |
66 | mh-treated | 1 |
67 | clopidogrel/aspirin-treated | 1 |
68 | hifu-treated | 2 |
69 | community-initiated | 2 |
70 | guideline-related | 1 |
71 | hookah-related | 6 |
72 | egfr-unselected | 1 |
73 | average-reported | 1 |
74 | da-supported | 1 |
75 | misconceived | 12 |
76 | unfollowed | 1 |
77 | rhd-alloimmunized | 1 |
78 | destigmatized | 1 |
79 | 172nd | 1 |
80 | asthma/copd | 9 |
81 | cme/ce | 2 |
82 | 8-ounce | 2 |
83 | purpose-made | 1 |
84 | sulfur-free | 3 |
85 | ganrantee | 1 |
86 | disease.the | 2 |
87 | unconsentable | 1 |
88 | at-scene | 4 |
89 | difficult-to-cure | 2 |
90 | difficult-to-ventilate | 1 |
91 | sulfasalazine-sensitive | 1 |
92 | pain-sensitive | 4 |
93 | beck-positive | 1 |
94 | ascites-positive | 1 |
95 | worse-off | 1 |
96 | worst-off | 1 |
97 | 80-kg | 2 |
98 | 93-kg | 1 |
99 | stone-forming | 17 |
100 | uncomplaining | 1 |
101 | sponge-using | 1 |
102 | igniting | 3 |
103 | reverifying | 1 |
104 | information-rich | 7 |
105 | moroccan-dutch | 2 |
106 | jth | 2 |
107 | high-cancer-risk | 1 |
108 | multi-structural | 1 |
109 | individual | 19,714 |
110 | post-alcohol-withdrawal | 1 |
111 | individual-level | 250 |
112 | poverty-level | 1 |
113 | line-item | 2 |
114 | nine-symptom | 1 |
115 | comparison.ten | 1 |
116 | 11-question | 2 |
117 | nine-question | 2 |
118 | d'un | 1 |
119 | pre-ecmo | 1 |
120 | pre-to-postsleep | 4 |
121 | non-sep | 1 |
122 | no-pcr | 1 |
123 | juror | 4 |
124 | child/your | 1 |
125 | hygiene/burroughs | 1 |
126 | dentulous | 2 |
127 | exiguous | 1 |
128 | ac-rct | 3 |
129 | kamlet-taft | 3 |
130 | inter-shift | 2 |
131 | end-digit | 5 |
132 | progesterone-deficient | 1 |
133 | lpl-deficient | 2 |
134 | home-sent | 2 |
135 | lamonica-oberst | 1 |
136 | frst | 1 |
137 | all-day | 18 |
138 | normal-energy | 2 |
139 | investigació | 1 |